← Leaderboards
Pamela S Hinds
St. Jude Children'S Research Hospital
$7,931,269
Attributed
$14,029,183
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,029,183 · 9
By mechanism
R01$12,970,599 · 5
R21$1,031,572 · 2
R13$14,780 · 1
M01$12,232 · 1
Top collaborators
- Lisa Schum Kahalley10 shared
- Donald Mabbott10 shared
- Bryce B Reeve9 shared
- Justin N Baker1 shared
- Leanne Embry1 shared
- David R Freyer1 shared
- Jennifer W Mack1 shared
- Lillian Sung1 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Brian P Sorrentino$13,809,294
- Ching-Hon Pui$668,290
- Yunping Zhu$109,128
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildMalignant NeoplasmsFatigueSiteQuality Of LifeSymptomsToxic EffectCancer PatientMedicalCognitiveBrainDesignMultidisciplinaryResearch InfrastructureQuestionnairesBaseParentsInterviewChildhoodPediatric Oncology GroupTheoriesReportingLifeFamily
Grant awards (36)
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$922,431
R01 · FY2025 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$237,541
R01 · FY2025 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$212,666
R01 · FY2025 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$19,727
R01 · FY2025 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$1,295,120
R01 · FY2024 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$115,672
R01 · FY2024 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$1,278,132
R01 · FY2023 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$37,978
R01 · FY2023 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$1,243,039
R01 · FY2022 · CA
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.$1,406,970
R01 · FY2021 · CA
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment$370,393
R01 · FY2021 · CA · contact PI
How Parent Constructs Affect Parent and Family Well-Being After a Child's Death$410,968
R01 · FY2018 · NR · contact PI
Creating and Validating Child Adverse Event Reporting in Oncology Trials$616,962
R01 · FY2017 · CA
How Parent Constructs Affect Parent and Family Well-Being After a Child's Death$425,112
R01 · FY2017 · NR · contact PI
Creating and Validating Child Adverse Event Reporting in Oncology Trials$14,711
R01 · FY2017 · CA
How Parent Constructs Affect Parent and Family Well-Being After a Child's Death$530,101
R01 · FY2016 · NR · contact PI
Creating and Validating Child Adverse Event Reporting in Oncology Trials$64,857
R01 · FY2016 · CA
Creating and Validating Child Adverse Event Reporting in Oncology Trials$1
R01 · FY2016 · CA
Creating and Validating Child Adverse Event Reporting in Oncology Trials$625,352
R01 · FY2015 · CA
How Parent Constructs Affect Parent and Family Well-Being After a Child's Death$525,660
R01 · FY2015 · NR · contact PI
Creating and Validating Child Adverse Event Reporting in Oncology Trials$64,857
R01 · FY2015 · CA
Creating and Validating Child Adverse Event Reporting in Oncology Trials$623,121
R01 · FY2014 · CA
Creating and Validating Child Adverse Event Reporting in Oncology Trials$48,511
R01 · FY2014 · CA
Creating and Validating Child Adverse Event Reporting in Oncology Trials$698,123
R01 · FY2013 · CA
Voices of children and adolescents with incurable cancer on Phase I or II Trials$202,656
R21 · FY2011 · NR · contact PI
Voices of children and adolescents with incurable cancer on Phase I or II Trials$266,416
R21 · FY2010 · NR · contact PI
HEALTH AND LITERACY IN CHILD AND ADULT ASSESSMENT: EXPANDED TESTING OF THE$12,232
M01 · FY2010 · RR · contact PI
Good Parent Intervention at End of Life$187,500
R21 · FY2005 · NR
Good Parent Intervention at End of Life$187,500
R21 · FY2004 · NR
SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER$322,811
R01 · FY2003 · NR
Good Parent Intervention at End of Life$187,500
R21 · FY2003 · NR
SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER$264,500
R01 · FY2002 · NR
SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER$56,613
R01 · FY2002 · NR
SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER$263,210
R01 · FY2001 · NR
SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER$275,460
R01 · FY2000 · NR
RESEARCH SUMMIT FOR PEDIATRIC ONCOLOGY NURSING$14,780
R13 · FY2000 · CA